Immune complications of chronic lymphocytic leukemia
https://doi.org/10.24884/1609-2201-2026-105-1-137-139
About the Author
K. V. RumyancevaRussian Federation
Karina V. Rumyanceva, hematologist, department and clinic of faculty therapy, department of intensive chemotherapy and myelotransplantation
Saint Petersburg
References
1. Chuchalin A. G., Avdeev S. N., Aisanov Z. R. et al. Sarcoidosis: federal clinical guidelines for diagnosis and treatment. Pulmonologiya. 2022;32(6):806‒833. (In Russ.). https://doi.org/10.18093/0869-0189-2022-32-6-806-833.
2. Diffuse parenchymal lung diseases / eds by M. M. Il'kovich. Moscow, GEOTAR-Media, 2021, 440 p. (In Russ.). https://doi.org/10.33029/9704-5908-9-DPL-2021-1-440. ISBN 978-5-97045908-9.
3. Baughman R. P., Valeyre D., Korsten P. et al. ERS clinical practice guidelines on treatment of sarcoidosis. Eur Respir J. 2021;58(6):2004079. https://doi.org/10.1183/13993003.040792020.
Review
For citations:
Rumyanceva K.V. Immune complications of chronic lymphocytic leukemia. New St. Petersburg Medical Records. 2026;(1):137-139. (In Russ.) https://doi.org/10.24884/1609-2201-2026-105-1-137-139
JATS XML
